Resources

Cohorts included nearly 200,000 American medical professionals…. Mu Chen, a doctoral candidate at the Harvard School of Public Health, said in a press release, “Our study benefited from having such a large sample size, high rates of follow-up and repeated assessment of dietary and lifestyle factors.” Chen and colleagues evaluated …

Higher A1C target recommended for patients over 65 with comorbidities… A team of Canadian and American researchers have analyzed data from the ACCORD trial to investigate whether the intensive lowering of glucose concentrations affects the risk of ischemic heart disease in patients with type 2 diabetes. The researchers assessed 10,251 …

Risk found unaffected by prolonged exposure to pioglitazone… According to a recent study of more than one million people published in Diabetologia, the diabetes medications pioglitazone (Actos) and rosiglitazone (Avandia) do not appear to have an association with bladder cancer. It is known that bladder tumors overexpress transcription factor called …

Poor glucose control speeds progression of dementia… A new study by researchers from Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, suggests that a midlife diagnosis of diabetes may accelerate the rate of cognitive decline over the following 20 years. Elizabeth Selvin, PhD, and her research team analyzed …

Study shows decrease in food intake and food-related brain responses… GLP-1 receptor agonists, currently used for the treatment of type 2 diabetes (T2DM), improve glycemic control and stimulate satiety, leading to decreases in food intake and body weight. Researchers hypothesized that food intake reduction after GLP-1 receptor activation is mediated …

GLP-1 agonist found to improved glycemic control, resulted in weight loss in type 2 adults with moderate renal impairment…

  Biodel’s glucagon device speeds the preparation process for lifesaving glucagon — and minimizes confusion. Traditional glucagon kits require users to inject liquid from a syringe into a vial of glucagon powder, shake the vial until the liquid turns clear, and withdraw the liquid into the syringe before injecting. Biodel’s …

Dr. Aaron Vinik discusses a very simple and quick device that can effectively detect neuropathy but also comments that it’s success is tied in to many other factors….

In this week’s Homerun Slides, Dr. Stanley Schwartz continues his review of pioglitazone as a therapy for both diabetes and cardiovascular issues. He shows how this medication is cardioprotective and that patients on this plus metformin do much better after hospitalization…. To download these slides in PowerPoint (.ppt) format, use this link: Diabetes …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Symptoms of sexual dysfunction affect both men and women with diabetes. The most common problem among men is erectile dysfunction (ED), which is defined as ‘the inability to achieve or maintain an erection sufficient for sexual intercourse’. ED occurs 10–15 years earlier …